Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study

We have previously hypothesized that pentoxifylline could be beneficial for the treatment of COVID-19 given its potential to restore the immune response equilibrium, reduce the impact of the disease on the endothelium and alveolar epithelial cells, and improve the circulatory function. Serum lactate...

Descripción completa

Detalles Bibliográficos
Autores principales: Maldonado, Valente, Hernandez-Ramírez, Claudia, Oliva-Pérez, Eniel Alonso, Sánchez-Martínez, César Omar, Pimentel-González, Jorge Fabián, Molina-Sánchez, José Raúl, Jiménez-Villalba, Yeimmy Zuyenn, Chávez-Alderete, Jaime, Loza-Mejía, Marco A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690298/
https://www.ncbi.nlm.nih.gov/pubmed/33278747
http://dx.doi.org/10.1016/j.intimp.2020.107209

Ejemplares similares

Ejemplares similares